AssayIndex
WXT cross-section

WXT by compound

WXT records split by compound, with the index-wide comparison for the same compound beside each one. 28 compounds, 353 records. Cells below n=3 print their raw values instead of a median.

28 compounds353 records
CompoundClassReportsWXT median %Index median %Δ (pp)SpecPass %
BPC-157Tissue-repair7298.3799.15-0.7898.078
SemaglutideIncretin5298.0298.87-0.8597.094
TB-500Tissue-repair2698.0399.47-1.4498.515
TirzepatideIncretin2198.1998.44-0.2597.090
SermorelinGrowth-hormone1498.2898.94-0.6698.079
IGF-1 LR3Growth-hormone1396.9397.75-0.8295.0100
SemaxNeuroactive1398.5099.17-0.6798.562
GHRP-6Growth-hormone1298.8899.65-0.7799.033
PT-141 (Bremelanotide)Melanocortin-receptor1198.9099.31-0.4198.564
LeuprolideHypothalamic1098.3499.01-0.6798.510
5-Amino-1MQNon-peptide1098.5099.24-0.7398.080
SelankNeuroactive1099.0199.13-0.1399.050
TesamorelinGrowth-hormone996.6698.43-1.7797.044
RetatrutideIncretin997.3598.41-1.0696.5100
LiraglutideIncretin996.7899.02-2.2397.50
IpamorelinGrowth-hormone898.0099.48-1.4899.013
GHRP-2Growth-hormone7 n=798.7899.22-0.4499.014
ARA-290Tissue-repair7 n=799.1899.45-0.2798.0100
Melanotan IIMelanocortin-receptor6 n=699.0999.24-0.1598.5100
CJC-1295 (no DAC)Growth-hormone6 n=698.1498.61-0.4798.083
SurvodutideIncretin6 n=698.0298.69-0.6796.5100
N-Acetyl Semax AmideNeuroactive5 n=598.1899.26-1.0898.540
MK-677 (Ibutamoren mesylate)Non-peptide5 n=599.4399.37+0.0698.5100
MOTS-cMetabolic4 n=498.0899.18-1.1198.050
CJC-1295 with DACGrowth-hormone4 n=497.5398.79-1.2697.550
L-Glutathione (reduced)Short2 n=2n<399.0098.50
PramlintideIncretin1 n=1n<398.8497.5100
Enclomiphene citrateNon-peptide1 n=1n<399.2398.5100
95.696.497.297.998.799.5100.2BPC-157BPC-157: Q1 98.09, median 98.37, Q3 99.07, n=72n=72SemaglutideSemaglutide: Q1 97.53, median 98.02, Q3 98.75, n=52n=52TB-500TB-500: Q1 97.81, median 98.03, Q3 98.30, n=26outlier 99.07outlier 99.17n=26TirzepatideTirzepatide: Q1 97.83, median 98.19, Q3 98.63, n=21outlier 99.93n=21SermorelinSermorelin: Q1 98.03, median 98.28, Q3 98.39, n=14outlier 98.94n=14IGF-1 LR3IGF-1 LR3: Q1 96.78, median 96.93, Q3 97.44, n=13n=13SemaxSemax: Q1 98.28, median 98.50, Q3 98.79, n=13n=13GHRP-6GHRP-6: Q1 98.49, median 98.88, Q3 99.11, n=12n=12PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 98.36, median 98.90, Q3 99.54, n=11n=11LeuprolideLeuprolide: Q1 97.97, median 98.34, Q3 98.44, n=10outlier 99.22n=105-Amino-1MQ5-Amino-1MQ: Q1 98.11, median 98.50, Q3 98.61, n=10n=10SelankSelank: Q1 98.67, median 99.01, Q3 99.28, n=10n=10TesamorelinTesamorelin: Q1 96.61, median 96.66, Q3 97.08, n=9n=9RetatrutideRetatrutide: Q1 97.28, median 97.35, Q3 97.54, n=9outlier 96.84n=9 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.